Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

  1. ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    4 Sep 2014

    Activity: Talk or presentation typesLecture and oral contribution

  2. ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer

    Andersen, Jesper Bøje (Speaker)

    2009

    Activity: Talk or presentation typesLecture and oral contribution

  3. ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation typesLecture and oral contribution

  4. ILCA: Molecular classification and key drivers of intrahepatic CCA

    Andersen, Jesper Bøje (Invited speaker)

    Sep 2017

    Activity: Talk or presentation typesLecture and oral contribution

  5. ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2010

    Activity: Talk or presentation typesLecture and oral contribution

  6. International Journal of Rare Diseases & Orphan Drugs (Journal)

    Andersen, Jesper Bøje (Member of Editorial Board)

    2016 → …

    Activity: Peer-review and editorial work typesEditor of Research journalResearch

  7. International Liver Cancer Association (ILCA) (External organisation)

    Andersen, Jesper Bøje (Member)

    2010

    Activity: Membership typesMembership in research network

  8. Journal of National Cancer Institute (Journal)

    Andersen, Jesper Bøje (Review editor)

    2007

    Activity: Peer-review and editorial work typesPeer review of manuscriptsResearch

ID: 93714085